{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for penicillin root_names_name in Any Name (approximate match)
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT03846453: Phase 3 Interventional Completed Dry Eye
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03858634: Phase 2 Interventional Completed Chronic Idiopathic Urticaria
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03337698: Phase 1/Phase 2 Interventional Active, not recruiting Carcinoma, Non-Small-Cell Lung
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02273960: Phase 1/Phase 2 Interventional Completed Immune Thrombocytopenic Purpura
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03663088: Not Applicable Interventional Terminated Idiopathic Scoliosis
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03943589: Phase 2 Interventional Completed Guillain-Barré Syndrome (GBS)
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:exbivirumab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02449239: Phase 3 Interventional Completed Bladder Cancer
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:libivirumab [INN]
Source URL:
Class:
PROTEIN
